Membrane Target Distribution in Antibody PK Models

Why Membrane-Target Location Matters

A membrane target is not distributed uniformly through the body simply because an antibody circulates in plasma. Antibody must reach a tissue before it can bind target there, and local target abundance determines how much antibody can be bound and, if complexes are internalized, removed. A model that places all target in one well-mixed compartment can therefore misrepresent both tissue exposure and the timing of target engagement.

A useful first extension of the canonical target-mediated drug disposition model is to distinguish a central compartment, representing plasma and rapidly accessible space, from a peripheral tissue compartment. The model can place membrane target in either or both. It does not describe detailed tissue architecture; instead, it represents entry into and exit from the peripheral compartment with an effective transport clearance.

Definition: Let \(A_c\) and \(A_p\) denote free antibody concentrations in the central and peripheral compartments, and let \(R_i\) and \(B_i\) denote free membrane-target and antibody-target-complex concentrations in compartment \(i\), where \(i\in\{c,p\}\). The compartment volumes are \(V_c\) and \(V_p\). Free antibody moves between compartments with transport clearance \(Q\), while membrane-bound complex is assumed to remain in the compartment where it forms.

Concentrations of target and complex are expressed in molar units, as is antibody concentration in the examples below. In applications using mass units for antibody, convert consistently or formulate the binding states in molar units. The product of a concentration and its compartment volume is an amount.

Two-Compartment Binding and Turnover Model

The following model uses linear transport of free antibody and local reversible binding. Antibody is supplied to the central compartment at rate \(u(t)\), and free antibody is cleared there with clearance \(CL\). In each compartment, association has rate constant \(k_{\mathrm{on},i}\), dissociation has rate constant \(k_{\mathrm{off},i}\), and internalization removes bound complex at rate constant \(k_{\mathrm{int},i}\).

V_c\frac{dA_c}{dt} = u(t)-CL\,A_c-Q(A_c-A_p) -V_c k_{\mathrm{on},c}A_cR_c +V_c k_{\mathrm{off},c}B_c

V_p\frac{dA_p}{dt} = Q(A_c-A_p) -V_p k_{\mathrm{on},p}A_pR_p +V_p k_{\mathrm{off},p}B_p

Transport is driven by the concentration difference: \(Q(A_c-A_p)\) is positive when antibody moves from central to peripheral space. Binding removes free antibody from the local free-drug state, and dissociation returns it. The associated target and complex equations in either compartment are

\frac{dR_i}{dt} = k_{\mathrm{syn},i}-k_{\mathrm{deg},i}R_i -k_{\mathrm{on},i}A_iR_i+k_{\mathrm{off},i}B_i, \qquad \frac{dB_i}{dt} = k_{\mathrm{on},i}A_iR_i -(k_{\mathrm{off},i}+k_{\mathrm{int},i})B_i

Here \(k_{\mathrm{syn},i}\) is the local target-production rate and \(k_{\mathrm{deg},i}\) is the degradation rate constant for free target. Without antibody, the target baseline is \(R_{0,i}=k_{\mathrm{syn},i}/k_{\mathrm{deg},i}\). Internalization removes complex and, in this model, the antibody bound in that complex is degraded. This is a simplifying assumption; if internalized antibody returns to the free pool, the corresponding return pathway must be included. The equations assume well-mixed concentrations within each compartment, mass-action binding, and no transport of membrane-bound complexes between compartments.

Mass Balance and a Transport Result

A useful implementation check is to add the amounts of free antibody and complex across the two compartments. Reversible binding terms cancel because association and dissociation transfer antibody between states rather than create or destroy it. The transport terms cancel because the amount leaving one compartment is the amount entering the other. Under the stated assumption that internalized antibody is degraded, the result is

\frac{d}{dt}\left(V_cA_c+V_pA_p+V_cB_c+V_pB_p\right) = u(t)-CL\,A_c -V_c k_{\mathrm{int},c}B_c -V_p k_{\mathrm{int},p}B_p

This balance is a diagnostic, not a substitute for solving the compartment equations. A simulation that gains antibody when \(u(t)=0\), or whose loss cannot be accounted for by clearance and internalization, likely contains a sign, volume, or unit error.

The role of transport is especially clear in the limiting case with no target, no elimination, and no input after an initial dose. The difference \(\Delta=A_c-A_p\) obeys

\frac{d\Delta}{dt} = -Q\left(\frac{1}{V_c}+\frac{1}{V_p}\right)\Delta

Thus the concentration difference decays exponentially, with rate \(Q(1/V_c+1/V_p)\). Transport does not change total antibody amount in this limiting case; it redistributes that amount. When target binding or elimination is present, the same transport process competes with local uptake and removal.

Worked Example: Redistribution After a Central Dose

Suppose a hypothetical antibody dose produces \(A_c(0)=100\) mg/L in a central volume \(V_c=3\) L, while \(A_p(0)=0\) mg/L in a peripheral volume \(V_p=12\) L. Assume \(Q=0.60\) L/day and, for this calculation only, no binding, input, or elimination. Find the compartment concentrations after four days.

The initial amount is \(3(100)+12(0)=300\) mg, so the final equilibrium concentration, if the compartments fully equilibrate, is \(300/(3+12)=20\) mg/L. The difference decays at rate \(0.60(1/3+1/12)=0.25\) per day. Therefore, after four days,

\Delta(4)=100e^{-0.25(4)}=36.79\ \mathrm{mg/L}

Conservation of amount gives \(3A_c+12A_p=300\), and \(A_c-A_p=36.79\). Solving these equations, \(A_c=20+(12/15)(36.79)=49.43\) mg/L and \(A_p=20-(3/15)(36.79)=12.64\) mg/L. The amounts are approximately \(148.3\) mg centrally and \(151.7\) mg peripherally, totaling 300 mg up to rounding. The central concentration remains higher because transport is finite, not instantaneous.

Local Target Abundance and Complex Formation

At a given tissue antibody concentration, target abundance governs the potential amount of complex. If binding is at equilibrium, internalization is negligible over the binding timescale, and total target \(R_{\mathrm{tot}}=R+B\) is conserved, the dissociation constant is \(K_D=k_{\mathrm{off}}/k_{\mathrm{on}}\). The equilibrium complex concentration is

B=R_{\mathrm{tot}}\frac{A}{K_D+A}

This expression is local: \(A\) is the free antibody concentration in the compartment containing that target. It does not imply that the tissue concentration equals the central concentration. Nor does the equilibrium expression apply unchanged when internalization or target turnover substantially alters the binding states.

Worked Example: Complex in a Target-Rich Tissue

In a hypothetical peripheral tissue, suppose free antibody is maintained at \(A_p=2.0\) nM, total membrane target is \(R_{\mathrm{tot},p}=8.0\) nM, and \(K_D=1.0\) nM. Assume reversible binding reaches equilibrium and internalization and target turnover are negligible during the calculation. The complex concentration is

B_p=8.0\frac{2.0}{1.0+2.0} =5.33\ \mathrm{nM}

The free target is \(R_p=8.0-5.33=2.67\) nM. In a tissue volume of 4.0 L, the complex amount is \(5.33\ \mathrm{nmol/L}\times4.0\ \mathrm{L}=21.3\) nmol. This calculation estimates local binding at a specified tissue antibody concentration; it does not predict how quickly the antibody reaches that concentration or how much complex is later internalized.

Transport-Limited Exposure with Target-Mediated Uptake

A compact steady-state approximation shows how transport and local target abundance jointly determine tissue exposure. Suppose the free target concentration \(R_p\) is approximately fixed, complex formation is at steady state, and the tissue contains no other antibody elimination pathway. From \(dB_p/dt=0\),

B_p=\frac{k_{\mathrm{on},p}A_pR_p} {k_{\mathrm{off},p}+k_{\mathrm{int},p}}

Internalization then removes antibody at rate \(V_p k_{\mathrm{int},p}B_p\), which is equivalent to a tissue target-mediated clearance \(CL_{\mathrm{TM},p}\) acting on \(A_p\):

CL_{\mathrm{TM},p} = V_p\frac{k_{\mathrm{int},p}k_{\mathrm{on},p}R_p} {k_{\mathrm{off},p}+k_{\mathrm{int},p}}, \qquad Q(A_c-A_p)=CL_{\mathrm{TM},p}A_p

The second equality is the steady-state peripheral free-antibody balance under these assumptions. Rearranging gives \(A_p/A_c=Q/(Q+CL_{\mathrm{TM},p})\). When \(Q\) is large relative to tissue uptake clearance, peripheral free antibody approaches the central concentration. When uptake clearance is large relative to \(Q\), the tissue concentration is depressed. The approximation requires a nearly constant free target; it is not reliable if target depletion is substantial.

Worked Example: Separating Tissue Entry from Local Uptake

Consider a hypothetical model with \(V_p=10\) L, \(Q=2.0\) L/day, \(R_p=50\) nM, \(k_{\mathrm{on},p}=0.20\) nM\(^{-1}\)day\(^{-1}\), \(k_{\mathrm{off},p}=0.50\) day\(^{-1}\), and \(k_{\mathrm{int},p}=0.50\) day\(^{-1}\). Assume the free-target concentration is maintained approximately constant, as required by the approximation. Then

CL_{\mathrm{TM},p} = 10\frac{(0.50)(0.20)(50)}{0.50+0.50} =50\ \mathrm{L/day}

For a central concentration \(A_c=10\) nM, the predicted peripheral concentration is \(A_p=10[2/(2+50)]=0.3846\) nM. The corresponding complex concentration is \(B_p=(0.20)(0.3846)(50)/(0.50+0.50)=3.846\) nM. The tissue internalization rate is \(10(0.50)(3.846)=19.23\) nM·L/day. Independently, transport into the tissue is \(2(10-0.3846)=19.23\) nM·L/day, as required at steady state.

If central clearance is \(0.50\) L/day, it removes \(0.50(10)=5.00\) nM·L/day. A steady input of \(24.23\) nM·L/day therefore balances central clearance plus tissue uptake: \(5.00+19.23=24.23\). The complex-to-free-target ratio is \(3.846/50=7.69\%\), supporting—but not proving—the assumption that the free target remains close to its maintained value. A model with explicit target turnover should replace this approximation when target depletion or replenishment materially affects the result.

Diagnostics, Alternatives, and Limitations

The main alternatives differ in how much spatial detail they retain. A single well-mixed compartment is appropriate when tissue equilibration is fast relative to the processes of interest, or when only aggregate exposure is needed. An instantaneous-equilibration approximation also removes the transport timescale, but cannot represent delayed tissue entry. The explicit central-peripheral model retains one transport timescale and permits distinct local target abundance and binding kinetics. A more detailed spatial or physiologically based model may be needed when tissue barriers, gradients, or multiple organs are central to the question; those added states require data to support their parameterization.

Several checks help identify when the two-compartment model is inadequate or incorrectly implemented:

Check amount balance. Verify that transport cancels across compartments and that antibody loss matches central clearance and complex internalization under the stated assumptions.
Check timescales. If observed tissue entry is much slower or more complex than one effective transport process can represent, a single \(Q\) may be insufficient.
Check target occupancy. If predicted complex is not small relative to target, a fixed-free-target approximation may fail. Use the explicit target and complex equations to capture depletion and turnover.
Check local units and volumes. Binding rates use concentrations; amounts in a compartment require multiplication by its volume. A missing volume factor can create apparent mass imbalance.
Check what is observed. Central plasma concentrations alone may not distinguish slow tissue transport from strong local uptake. Tissue exposure or target-engagement data can help separate these mechanisms.

A common mistake is to treat a large tissue target pool as if it immediately lowers the central concentration by the same amount. That reasoning ignores transport: target can bind only antibody that reaches its compartment, and the speed of access depends on \(Q\). Another error is to interpret \(CL_{\mathrm{TM},p}\) as a fixed clearance in every regime. In the derivation it depends on an approximately fixed free target; if target is depleted, complex formation and uptake can change as antibody exposure changes.

Key takeaway: Membrane-target disposition is determined by both local binding and access to the target-bearing tissue. Keep free antibody, target, and complex in their proper compartments, and verify that transport, binding, and internalization terms preserve the intended mass balance.

Check Your Understanding

Answer each question, then compare with the brief solutions.

If \(Q=0\) and the only target is peripheral, can that target directly bind antibody in the central compartment? Explain.
With no target, elimination, or input, what happens to the total amount \(V_cA_c+V_pA_p\) during transport?
At equilibrium, \(A=3\) nM, \(R_{\mathrm{tot}}=6\) nM, and \(K_D=3\) nM. Calculate the complex concentration under the reversible-binding assumptions.
In the fixed-free-target approximation, what happens to the ratio \(A_p/A_c\) as \(Q\) becomes much larger than \(CL_{\mathrm{TM},p}\)?
Name one observation or model check that could help reveal a failure of the two-compartment approximation.

Solutions. (1) No. With \(Q=0\), no free antibody moves from central to peripheral space, so the peripheral target cannot bind central antibody in this model. (2) It remains constant; transport redistributes antibody but does not create or remove it. (3) \(B=6[3/(3+3)]=3\) nM. (4) \(A_p/A_c=Q/(Q+CL_{\mathrm{TM},p})\) approaches 1, so the compartments approach equal free concentrations. (5) Examples include tissue concentration data showing delayed or multistage entry, or a simulation mass-balance check showing unexplained antibody gain or loss.